The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA

The SARS-CoV-2 Spike glycoprotein (S protein) acquired a unique new 4 amino acid -PRRA- insertion sequence at amino acid residues (aa) 681–684 that forms a new furin cleavage site in S protein as well as several new glycosylation sites. We studied various statistical properties of the -PRRA- inserti...

Full description

Bibliographic Details
Main Authors: Olga A. Postnikova, Sheetal Uppal, Weiliang Huang, Maureen A. Kane, Rafael Villasmil, Igor B. Rogozin, Eugenia Poliakov, T. Michael Redmond
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/12/6490
id doaj-0a8bc8b857ed4f0887dec003129626ac
record_format Article
spelling doaj-0a8bc8b857ed4f0887dec003129626ac2021-07-01T00:24:43ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-01226490649010.3390/ijms22126490The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNAOlga A. Postnikova0Sheetal Uppal1Weiliang Huang2Maureen A. Kane3Rafael Villasmil4Igor B. Rogozin5Eugenia Poliakov6T. Michael Redmond7Laboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USADepartment of Pharmaceutical Sciences, School of Pharmacy Mass Spectrometry Center, University of Maryland, Baltimore, MD 21201, USADepartment of Pharmaceutical Sciences, School of Pharmacy Mass Spectrometry Center, University of Maryland, Baltimore, MD 21201, USAFlow Cytometry Core Facility, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USANational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USALaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USAThe SARS-CoV-2 Spike glycoprotein (S protein) acquired a unique new 4 amino acid -PRRA- insertion sequence at amino acid residues (aa) 681–684 that forms a new furin cleavage site in S protein as well as several new glycosylation sites. We studied various statistical properties of the -PRRA- insertion at the RNA level (CCUCGGCGGGCA). The nucleotide composition and codon usage of this sequence are different from the rest of the SARS-CoV-2 genome. One of such features is two tandem CGG codons, although the CGG codon is the rarest codon in the SARS-CoV-2 genome. This suggests that the insertion sequence could cause ribosome pausing as the result of these rare codons. Due to population variants, the Nextstrain divergence measure of the CCU codon is extremely large. We cannot exclude that this divergence might affect host immune responses/effectiveness of SARS-CoV-2 vaccines, possibilities awaiting further investigation. Our experimental studies show that the expression level of original RNA sequence “wildtype” spike protein is much lower than for codon-optimized spike protein in all studied cell lines. Interestingly, the original spike sequence produces a higher titer of pseudoviral particles and a higher level of infection. Further mutagenesis experiments suggest that this dual-effect insert, comprised of a combination of overlapping translation pausing and furin sites, has allowed SARS-CoV-2 to infect its new host (human) more readily. This underlines the importance of ribosome pausing to allow efficient regulation of protein expression and also of cotranslational subdomain folding.https://www.mdpi.com/1422-0067/22/12/6490ribosome stallingSARS-CoV-2spike proteincodon usageribosome pausing site
collection DOAJ
language English
format Article
sources DOAJ
author Olga A. Postnikova
Sheetal Uppal
Weiliang Huang
Maureen A. Kane
Rafael Villasmil
Igor B. Rogozin
Eugenia Poliakov
T. Michael Redmond
spellingShingle Olga A. Postnikova
Sheetal Uppal
Weiliang Huang
Maureen A. Kane
Rafael Villasmil
Igor B. Rogozin
Eugenia Poliakov
T. Michael Redmond
The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
International Journal of Molecular Sciences
ribosome stalling
SARS-CoV-2
spike protein
codon usage
ribosome pausing site
author_facet Olga A. Postnikova
Sheetal Uppal
Weiliang Huang
Maureen A. Kane
Rafael Villasmil
Igor B. Rogozin
Eugenia Poliakov
T. Michael Redmond
author_sort Olga A. Postnikova
title The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
title_short The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
title_full The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
title_fullStr The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
title_full_unstemmed The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
title_sort functional consequences of the novel ribosomal pausing site in sars-cov-2 spike glycoprotein rna
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-06-01
description The SARS-CoV-2 Spike glycoprotein (S protein) acquired a unique new 4 amino acid -PRRA- insertion sequence at amino acid residues (aa) 681–684 that forms a new furin cleavage site in S protein as well as several new glycosylation sites. We studied various statistical properties of the -PRRA- insertion at the RNA level (CCUCGGCGGGCA). The nucleotide composition and codon usage of this sequence are different from the rest of the SARS-CoV-2 genome. One of such features is two tandem CGG codons, although the CGG codon is the rarest codon in the SARS-CoV-2 genome. This suggests that the insertion sequence could cause ribosome pausing as the result of these rare codons. Due to population variants, the Nextstrain divergence measure of the CCU codon is extremely large. We cannot exclude that this divergence might affect host immune responses/effectiveness of SARS-CoV-2 vaccines, possibilities awaiting further investigation. Our experimental studies show that the expression level of original RNA sequence “wildtype” spike protein is much lower than for codon-optimized spike protein in all studied cell lines. Interestingly, the original spike sequence produces a higher titer of pseudoviral particles and a higher level of infection. Further mutagenesis experiments suggest that this dual-effect insert, comprised of a combination of overlapping translation pausing and furin sites, has allowed SARS-CoV-2 to infect its new host (human) more readily. This underlines the importance of ribosome pausing to allow efficient regulation of protein expression and also of cotranslational subdomain folding.
topic ribosome stalling
SARS-CoV-2
spike protein
codon usage
ribosome pausing site
url https://www.mdpi.com/1422-0067/22/12/6490
work_keys_str_mv AT olgaapostnikova thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT sheetaluppal thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT weilianghuang thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT maureenakane thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT rafaelvillasmil thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT igorbrogozin thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT eugeniapoliakov thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT tmichaelredmond thefunctionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT olgaapostnikova functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT sheetaluppal functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT weilianghuang functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT maureenakane functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT rafaelvillasmil functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT igorbrogozin functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT eugeniapoliakov functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
AT tmichaelredmond functionalconsequencesofthenovelribosomalpausingsiteinsarscov2spikeglycoproteinrna
_version_ 1721348696692490240